The coronavirus will not wait for the historically glacial pace of drug development. A vaccine, we have been repeatedly warned, is at least 12 to 18 months away. The more immediate focus is on identifying drugs already licensed and effective in treating those who suffer the most severe effects of Covid-19.
This is why pharma companies are rummaging through their archives to see if anything fits the bill when it comes to treating the very specific complications...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team